Can GoodRx Bounce Back From Its Pandemic Slowdown?

1 min read

The COVID-19 pandemic produced a growth slowdown at pharmaceutical drug discounter GoodRx Holdings (NASDAQ: GDRX). If patients aren’t going to their doctors, they’re not going to need drug discounts. The increase in physical distancing also blunted the flu season, which further reduced the need for medications. In this video from Motley Fool Live, recorded on March 15, Fool.com Contributors Brian Orelli and Keith Speights discuss what outside factors could help GoodRx accelerate growth in the quarters to come.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Better Buy: Facebook vs. Twitter

Next Story

Could Box and Dropbox Merge?

Latest from Blog

Is Callaway Stock a Buy?

On March 8, golf equipment giant Callaway (NYSE: ELY) finalized its merger with sports entertainment and…